Cargando…
PD-1 inhibitor toripalimab with gemcitabine as a neoadjuvant therapy for muscle-invasive bladder urothelial carcinoma: A case report
RATIONALE: Routine neoadjuvant therapy for muscle-invasive bladder urothelial carcinoma prior to radical surgery is curative. With the increase in cancer immunotherapy, neoadjuvant immunotherapy has been used as an important complement to neoadjuvant chemotherapy for muscle-invasive urothelial carci...
Autores principales: | Yin, Huaqi, Yongkang, Ma, Bao, Guan, Shiming, Zhao, Chaohong, He, Tiejun, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757928/ https://www.ncbi.nlm.nih.gov/pubmed/35029241 http://dx.doi.org/10.1097/MD.0000000000028591 |
Ejemplares similares
-
Case report: Gemcitabine intravesical hyperthermic infusion combined with tislelizumab in muscle invasive bladder urothelium carcinoma
por: Du, Zheng, et al.
Publicado: (2022) -
Deceptive Muscle Invasive Bladder Cancer Recurrence With Benign Biopsy Foci After Bladder Sparing Treatment
por: Xu, Chuanliang, et al.
Publicado: (2015) -
Urothelial carcinoma of the bladder with abundant myxoid stroma: A case report and literature review
por: Tao, Ting-Ting, et al.
Publicado: (2020) -
Rapid testicular metastasis from bladder transitional urothelial carcinoma after radical cystoprostatectomy: A case report
por: Wu, Kaijie, et al.
Publicado: (2019) -
Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Kim, Hongsik, et al.
Publicado: (2023)